The present invention provides a PDL-1 molecule wherein the affinity of the PDL-1 molecule and the PD-1 molecule is at least twice the affinity of the wild-type PDL-1 molecule and the PD-1 molecule. At the same time, the PDL-1 molecule of the present invention can effectively improve the killing ability of lymphocytes. Furthermore, the present invention provides a nucleic acid encoding the PDL-1 molecule of the invention and a complex of the PDL-1 molecule of the invention. The PDL-1 molecule of the present invention may be used alone or in combination with other molecules.